Astrazeneca

The approval will open doors for Biocon in more than 15 European countries. (Image: iStock)

Biocon receives first generic approval in EU

By Melissa Fassbender

Biocon, an Indian biopharmaceuticals company, has received European approvals for its Rosuvastatin Calcium, a generic equivalent of AstraZeneca’s Crestor tablets.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers